At the 2022 American Psychiatric Association (APA) annual meeting, Israeli generics giant Teva Pharmaceutical will present new data for Austedo (deutetrabenazin 24 May 2022
About 100 generic medicines are set to be suspended from use in Europe, after a scientific panel of the European Medicines Agency reviewed evidence of irregular 23 May 2022
The Medicines Patent Pool (MPP) has signed agreements with 35 companies to manufacture the generic version of Pfizer’s oral COVID-19 treatment Paxlovid (nirmatr 17 March 2022
Sign up to receive email updates Join industry leaders for a daily roundup of biotech & pharma news
Company Spotlight
USA-based Insmed (NASDAQ CM: INSM) is a biopharmaceutical company on the development and commercialization of novel, targeted inhaled therapies for patients with serious rare diseases.